Glucagon-like peptide-1 analogs

Details Glucagon-like peptide-1 analogs Glucagon-like peptide-1 analogs

1998-03-25

1999-11-09

Celsa, Bennett

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

530308, 530324, A61K 3826, C07K 14605

Patent

active

059814888

ABSTRACT:
The invention provides extended-action GLP-1 based peptides and compositions that are useful for treating diabetes and minimize the risk of hypoglycemia.

REFERENCES:
patent: 4347374 (1982-08-01), Kollonitsch et al.
patent: 5118666 (1992-06-01), Habener
patent: 5120712 (1992-06-01), Habener
patent: 5614492 (1997-03-01), Habener
patent: 5705483 (1998-01-01), Golloway et al.
Komatsu, R., et al., Diabetes, 38:902-905 (1989).
Orskov, C., et al., J. Biol. Chem., 264(22):12826-12829 (1989).
Majsov, S., Int. J. Peptide Protein Res., 40:333-343 (1989).
Holz, G.G., et al., Nature, 361:362-365 (1993).
Orskov, C. , Diabetologia, 35:701-711 (1992).
Mentlein, R., et al., Eur. J. Biochem., 214:829-835 (1993).
Handbook of Experimental Pharmacology, Springer-Verlag, Hasselblatt, et al., (Eds.), 32 (2):729-777 (1975).
Nauck, M.A., et al., J. Clin. Invest., 91:301-307 (1993).
Nauck, M.A. et al. , Diabetologia, 36:741-744 (1993).
Gutniak, M., et al., N. E. J. Med., 326(20):1316-1322, (1992).
Thorens B., et al., Diabetes, 42:1219-1225 (1993).
Levine-Pinto, H. et al., Biochem. Biophys. Red. Commun., 103 (4) :1121-1130 (1981).
Owa, T., et al., Chem. Letters: 873-874 (1988).
Altman, J., et al., Synthetic Commun., 19(11 & 12) :2069-2076 (1989).
O'Donnell, J.J. et al., Synthetic Commun., 19(7 & 8): 1157-1165 (1989).
Galloway, J.A., Diabetes Care, 13:1209-1239, (1990).
Galloway, J.A., et al., Clin. Therap., 12:460-472, (1990).
Suzuki, S., et al., Endocrinology, 125, 3109-3114, (1990).
Ananthanancayanan, V.V., et al., Mol. Biol. Cell (Supp) 3, 250A 1452 (1992).
Epand, R.M., Mol. Pharmacol., 22:105-108 (1982).
Pridal, L., et al., "Absorption of Glucagon-Like Peptide-1 Can Be Protracted by Zinc or Protamine", International Journal of Pharmaceuticals, 136 (1996) 53-59.

Affiliated with

Also associated with

Rating

Glucagon-like peptide-1 analogs does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Glucagon-like peptide-1 analogs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glucagon-like peptide-1 analogs will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1456002